The Canadian Patent Office (CIPO) has advised that as of January 14, 2025, it had granted patents for which final fees were processed in the old system. CIPO has started to process applications where final fees were paid in the Next Generation Patents (NGP) system, and has started granting these patents. The Canadian Patent Database will indicate the status of patents as “Pre-grant”, which means that the final fee payment has been processed and determined compliant.
CIPO is temporarily publishing a List of “Pre-grant” applications that indicates a predicted grant date, with a new file posted weekly normally on Thursday. CIPO has warned that this is not a guaranteed grant date, but if not granted on the predicted date, the patent should be granted the following week.
The weekly list of granted and issued patents is also posted by CIPO, normally posted on Tuesdays.
The preceding is intended as a timely update on Canadian intellectual property and life sciences regulatory law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.
Related Publications & Articles
-
Health Canada finalizes biosimilar guidance: comparative clinical efficacy studies not typically required
In Canada, biosimilar products are approved by way of a new drug submission, following Health Canada guidance first released in 2010 and significantly revised in 2016.Read More -
2026 mid-year highlights in Canadian life sciences IP and regulatory law
In the first half of 2026, the Rx IP Update team reported on a number of developments in Canadian life sciences IP and regulatory law. Below are our top storiesRead More -
Supreme Court of Canada: methods of medical treatment unpatentable, validity of Janssen’s paliperidone dosing regimen patent upheld
Today the Supreme Court of Canada released its decision in Pharmascience Inc v Janssen Inc, 2026 SCC 26 on the patentability of methods of medical treatment, dismissing Pharmascience’s appeal.Read More
